Rampart Investment Management Company, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rampart Investment Management Company, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$36,000
-64.7%
1,956
-31.9%
0.00%
-66.7%
Q2 2019$102,000
+1.0%
2,871
-4.9%
0.01%
+9.1%
Q1 2019$101,000
+62.9%
3,020
+61.2%
0.01%
-35.3%
Q4 2018$62,000
-99.9%
1,873
-77.2%
0.02%
-64.6%
Q3 2018$109,450,000
+20281.8%
8,230
-25.2%
0.05%
-9.4%
Q2 2018$537,00010,9990.05%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders